pentobarbital has been researched along with Angor Pectoris in 2 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kato, K | 1 |
| Fukuda, H | 1 |
| Koyama, S | 1 |
| Bernreiter, M | 1 |
2 other studies available for pentobarbital and Angor Pectoris
| Article | Year |
|---|---|
Depression of the S-T segment in epicardial electrocardiogram associated with experimental major coronary artery constriction.
Topics: Angina Pectoris; Animals; Coronary Disease; Coronary Vessels; Dogs; Electrocardiography; Electrodes; | 1968 |
Drug reaction. Severe angina pectoris and electrocardiographic changes after Cafergot medication.
Topics: Angina Pectoris; Caffeine; Electrocardiography; Ergotamine; Humans; Middle Aged; Pentobarbital | 1965 |